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Seok Jin Kim1,5, Kyung Ju Ryu2, Mineui Hong3, Young Hyeh Ko4 and Won Seog Kim1*Unfortunately, the original version of this article [1]
contained an error. The legend for Table 2 was included
incorrectly. The corrected legend is ‘The association of
CXCL13 with unfavourable parameters’.
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